The Venture Codex Logo

The Venture Codex

K2 Venture Partners

29 Floors, Taikang Financial Building, No. 38 East Third Ring North Road, Chaoyang District, Beijing, 100026, China

Overview

Early stage investment in technology start-ups in China.

Founded

2010

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

China
United States

Sector focus

Venture Capital

Investment portfolio

7rounds
NAMEDATESIZE
Sanegene Bio
Dec 2025Participated
$110 MSeries B
LTZ Therapeutics
Jul 2024Participated
$20 MSeries A
Sanegene Bio
Dec 2023Participated
$84 MSeries A
LTZ Therapeutics
May 2023Participated
$10 MSeries A
Sironax
Aug 2022Participated
$200 MSeries B
Circular Code Biology
Jun 2022Led
$20 MSeries A
LTZ Therapeutics
Apr 2022Led
$17 MSeries A
Sanegene Bio
Dec 2025Participated
$110 MSeries B
LTZ Therapeutics
Jul 2024Participated
$20 MSeries A
Sanegene Bio
Dec 2023Participated
$84 MSeries A
LTZ Therapeutics
May 2023Participated
$10 MSeries A
Sironax
Aug 2022Participated
$200 MSeries B
Circular Code Biology
Jun 2022Led
$20 MSeries A
LTZ Therapeutics
Apr 2022Led
$17 MSeries A
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

K2 Venture Partners: 7 funding rounds are recorded in the selected participation categories.All available history.
K2 Venture Partners: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A23
Series B02

Monthly Deal Activity

K2 Venture Partners: 7 deals are recorded across 55 months.All available history.
K2 Venture Partners: 7 deals are recorded across 55 months. All available history
MonthDeals
Apr '221
May '220
Jun '221
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

K2 Venture Partners: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

K2 Venture Partners: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7

Deal Size Distribution

K2 Venture Partners: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

K2 Venture Partners: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M4
$25M-$50M0
$50M-$100M1
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

K2 Venture Partners: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

K2 Venture Partners: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
China2
K2 Venture Partners: 20 co-investors are shown, with Qiming Venture Partners sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

K2 Venture Partners: 20 co-investors are shown, with Qiming Venture Partners sharing 4 recorded deals. All available history
Co-investorShared deals
Qiming Venture Partners4
Invus2
Northern Light Venture Capital2
Shunwei Capital2
Tencent2
TF Capital2
Abu Dhabi Investment Authority1
ARCH Venture Partners1
CBC Group1
Efung Capital1
Eight Roads Ventures1
Eli Lilly and Company1
F-Prime Capital1
Future Innovation Fund1
Gaorong Capital1
GL Ventures1
Kaitai Capital1
Lake Bleu Capital1
Lapam Capital1
Legend Capital1

Investment Strategy

K2 Venture Partners: Led accounts for 29% and participating for 71% of round participation.All available history.
K2 Venture Partners: Led accounts for 29% and participating for 71% of round participation. All available history
CategoryDeals (count)Share (%)
Led229%
Participating571%
K2 Venture Partners: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
K2 Venture Partners: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Azur Han

Investment analyst

Fan Bao

Founding Partner

Keyi Chen

Co-Founding Partner & Managing Director

Shiyu Wang

Partner

Yang Runxin

Vice President

Zhao Yang

Managing Partner